Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Nuclear Transmutation03:20

Nuclear Transmutation

18.7K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
18.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer metabolism: from the Warburg effect to precision therapy.

Frontiers in immunology·2026
Same author

The new era of immunotherapy for breast cancer: challenges and coping strategies of CAR-T cell therapy.

Frontiers in immunology·2025
Same author

Research overview and hotspots in the field of recurrent miscarriage: A literature-mining study.

Frontiers in medicine·2025
Same author

Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs) for cervical cancer: A bibliometric study from 2014 to 2024.

Human vaccines & immunotherapeutics·2025
Same author

Global research hotspots and trends in DNA vaccine research: A bibliometric and visualization study from 2014 to 2024.

Human vaccines & immunotherapeutics·2025
Same author

Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012-2023).

Human vaccines & immunotherapeutics·2024

Related Experiment Video

Updated: Sep 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Boron Neutron Capture Therapy: Current Status and Challenges.

Song Wang1,2, Zhengchao Zhang1,2, Lele Miao1,2

  • 1Department of General Surgery, Second Hospital of Lanzhou University, Lanzhou, China.

Frontiers in Oncology
|April 18, 2022
PubMed
Summary

Boron neutron capture therapy (BNCT) selectively targets tumor cells using boron delivery agents and neutron activation. Current challenges involve developing better agents and accurate dose measurement systems for this unique radiotherapy.

Keywords:
boron delivery agentboron neutron capture therapy (BNCT)radiationthermal neutrontumor

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.9K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Related Experiment Videos

Last Updated: Sep 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.9K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Area of Science:

  • Oncology
  • Radiotherapy
  • Nuclear Medicine

Background:

  • Boron neutron capture therapy (BNCT) is a targeted radiotherapy that selectively destroys tumor cells.
  • It utilizes boron-containing compounds that accumulate in tumors, followed by neutron irradiation to release therapeutic particles.
  • BNCT offers advantages of targeted action and low toxicity, making it a distinct approach in cancer treatment.

Purpose of the Study:

  • To review the evolution and clinical applications of boron delivery agents in BNCT.
  • To analyze preclinical and clinical outcomes associated with BNCT.
  • To provide recommendations for future advancements in boron delivery agents and BNCT.

Main Methods:

  • Review of historical development of boron delivery agents for BNCT.
  • Analysis of clinical trials and preclinical data on BNCT efficacy.
  • Discussion of current challenges and future directions in BNCT research.

Main Results:

  • BNCT has been developed as a treatment for various cancers, including glioblastoma multiforme, head and neck cancers, and malignant melanoma.
  • Significant progress has been made in understanding boron delivery agents and their therapeutic effects.
  • Key challenges remain in optimizing boron delivery and dose measurement for enhanced treatment outcomes.

Conclusions:

  • BNCT is a promising, selective cancer therapy with a growing role in radiotherapy.
  • Continued innovation in boron delivery agents and dosimetry is crucial for the advancement of BNCT.
  • Future research should focus on developing more effective agents and precise measurement systems to maximize BNCT's potential.